In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks with potential to explode in 2025. The recent pullback in US equities can be a sign of ...

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them, asks ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Have you been paying attention to current events recently? See how many of these 10 questions you can get right. Compiled by Jeremy Engle In an illustrated story, a guest author describes how ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

After hours: 21 March at 19:58:23 GMT-4 Loading Chart for MRNA ...